DK0965588T3 - Fremgangsmåde til fremstilling af 4-phenyl-1,2,3,6-tetrahydropyridinderivater og mellemprodukter anvendt ved denne fremgangsmåde - Google Patents

Fremgangsmåde til fremstilling af 4-phenyl-1,2,3,6-tetrahydropyridinderivater og mellemprodukter anvendt ved denne fremgangsmåde

Info

Publication number
DK0965588T3
DK0965588T3 DK99401497T DK99401497T DK0965588T3 DK 0965588 T3 DK0965588 T3 DK 0965588T3 DK 99401497 T DK99401497 T DK 99401497T DK 99401497 T DK99401497 T DK 99401497T DK 0965588 T3 DK0965588 T3 DK 0965588T3
Authority
DK
Denmark
Prior art keywords
reacting
compound
formula
phenyl
agent
Prior art date
Application number
DK99401497T
Other languages
English (en)
Inventor
Francis Brion
Christian Richard
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0965588T3 publication Critical patent/DK0965588T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK99401497T 1998-06-18 1999-06-17 Fremgangsmåde til fremstilling af 4-phenyl-1,2,3,6-tetrahydropyridinderivater og mellemprodukter anvendt ved denne fremgangsmåde DK0965588T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9807677A FR2780056B1 (fr) 1998-06-18 1998-06-18 Nouveau procede de preparation de derives de la 4-phenyl-1-2 3,6-tetrahydropyridine et les produits imtermediaires mis en oeuvre

Publications (1)

Publication Number Publication Date
DK0965588T3 true DK0965588T3 (da) 2004-06-21

Family

ID=9527532

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99401497T DK0965588T3 (da) 1998-06-18 1999-06-17 Fremgangsmåde til fremstilling af 4-phenyl-1,2,3,6-tetrahydropyridinderivater og mellemprodukter anvendt ved denne fremgangsmåde

Country Status (11)

Country Link
US (1) US6136981A (da)
EP (1) EP0965588B1 (da)
JP (1) JP4538114B2 (da)
AT (1) ATE261432T1 (da)
CA (1) CA2275192C (da)
DE (1) DE69915413T2 (da)
DK (1) DK0965588T3 (da)
ES (1) ES2213991T3 (da)
FR (1) FR2780056B1 (da)
HU (1) HU225621B1 (da)
PT (1) PT965588E (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5981747B2 (ja) * 2012-03-28 2016-08-31 東ソー・ファインケム株式会社 アザディールス−アルダー反応用触媒、それを用いたテトラヒドロピリジン化合物の製造方法
CA2982928A1 (en) 2015-04-20 2016-10-27 Tolero Pharmaceuticals, Inc. Predicting response to alvocidib by mitochondrial profiling
EP3298021B1 (en) 2015-05-18 2019-05-01 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs having increased bioavailability
US10568887B2 (en) 2015-08-03 2020-02-25 Tolero Pharmaceuticals, Inc. Combination therapies for treatment of cancer
WO2018094275A1 (en) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
CN110234659A (zh) 2016-12-19 2019-09-13 特雷罗药物股份有限公司 用于敏感性分析的分析肽和方法
US11497756B2 (en) 2017-09-12 2022-11-15 Sumitomo Pharma Oncology, Inc. Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
KR20210099066A (ko) 2018-12-04 2021-08-11 스미토모 다이니폰 파마 온콜로지, 인크. 암의 치료를 위한 작용제로서 사용하기 위한 cdk9 억제제 및 그의 다형체
JP2022525149A (ja) 2019-03-20 2022-05-11 スミトモ ダイニッポン ファーマ オンコロジー, インコーポレイテッド ベネトクラクスが失敗した急性骨髄性白血病(aml)の処置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2338043A1 (fr) * 1976-01-13 1977-08-12 Delmar Chem Derives de 4-arylpiperidine et procedes de production
US4132710A (en) * 1976-12-20 1979-01-02 Ayerst, Mckenna And Harrison, Ltd. [2]Benzopyrano[3,4-c]pyridines and process therefor
US5849733A (en) * 1996-05-10 1998-12-15 Bristol-Myers Squibb Co. 2-thio or 2-oxo flavopiridol analogs
US6268499B1 (en) * 1998-08-10 2001-07-31 Hoffman-La Roche Inc. Process and intermediates for preparation of substituted piperidine-epoxides

Also Published As

Publication number Publication date
FR2780056B1 (fr) 2000-08-04
ATE261432T1 (de) 2004-03-15
CA2275192C (fr) 2008-12-30
HU225621B1 (en) 2007-05-02
DE69915413D1 (de) 2004-04-15
ES2213991T3 (es) 2004-09-01
HUP9902040A2 (hu) 2001-11-28
HU9902040D0 (en) 1999-08-30
PT965588E (pt) 2004-07-30
CA2275192A1 (fr) 1999-12-18
DE69915413T2 (de) 2004-08-19
JP4538114B2 (ja) 2010-09-08
FR2780056A1 (fr) 1999-12-24
EP0965588B1 (fr) 2004-03-10
US6136981A (en) 2000-10-24
EP0965588A1 (fr) 1999-12-22
JP2000026418A (ja) 2000-01-25

Similar Documents

Publication Publication Date Title
DK1254883T3 (da) Fremgangsmåde til fremstilling af substitueret 1,1,1-trifluoro-3-butene-2-oner
DK0758335T3 (da) Fremstilling af et camptothecinderivat ved intramolekylær ringslutning
DK0629609T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamidderivater og et mellemprodukt dertil
NO992549L (no) Sukkerforbindelse, geleringsmiddel og fremgangsmåte for fremstilling derav
DK0965588T3 (da) Fremgangsmåde til fremstilling af 4-phenyl-1,2,3,6-tetrahydropyridinderivater og mellemprodukter anvendt ved denne fremgangsmåde
DK0532515T3 (da) Fremstilling af substituerede piperidiner
DE60333733D1 (en) Clohexancarbonsäurederivats
AU1224799A (en) Process for the preparation of 1,4-dihydropyridines and compounds used in this process
DK0565558T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af azabicyclo(2.2.2)octan-3-iminer
KR920012023A (ko) 아릴피롤 화합물의 제조방법
DK0781764T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
DK0574317T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af 20-keto-21alpha-hydroxysteroider og mellemprodukter dertil
PL349933A1 (en) Novel compounds beta-hydroxyalylamides, method of obtaining them and their application
IN184319B (da)
DE69906243T2 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
DK0613896T3 (da) Fremgangsmåde til fremstilling af sulfonylurinstofderivater
CA2101252A1 (en) Process for preparing trans-piperidine-2,5- dicarboxylates
IT1313702B1 (it) Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
DK0490063T3 (da) Fremgangsmåde til fremstilling af insekticide, acaricide og molluscicide 2-halopyrrol-3-carbonitrilforbindelser
AU751914C (en) Amine derivatives and process for producing the same
NO903514D0 (no) Imidazolderivat og fremgangsmaate til dets fremstilling.
DE68914211D1 (de) Verfahren zur Herstellung von Zwischenprodukten in der Synthese von Diltiazem.
DK1202948T3 (da) Fremgangsmåder til fremstilling af 2-arylvinylalkylethere og 1,4-aryl-2-fluor-2-butenforbindelser
DE69422495D1 (de) Chinolondisulfide als zwischenverbindungen
AU3170399A (en) Process for producing arylsulfenyl halide